Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Chronic Renal Failure

  Free Subscription


Articles published in J Nephrol

Retrieve available abstracts of 307 articles:
HTML format



Single Articles


    September 2026
  1. BISWAS S, Srivastava Y, Nour AA
    Chronic Kidney Disease Stage and Hospital Mortality in Critically Ill Adults.
    J Nephrol. 2026 Sep 26:aajag250. doi: 10.1093.
    PubMed    


  2. RANA G, Cirillo P, Acquaviva PM, Falco E, et al
    Glow-food illuminating nutritional value and enhancing taste in chronic kidney disease: a Mediterranean perspective.
    J Nephrol. 2026 Sep 15:aajag140. doi: 10.1093.
    PubMed     Abstract available


  3. KOBAYASHI R, Mori S, Yoshikoshi S, Matsui M, et al
    Serum N-terminal pro-B-type natriuretic peptide and physical performance in middle-aged and older patients with chronic kidney disease.
    J Nephrol. 2026 Sep 15:aajag036. doi: 10.1093.
    PubMed     Abstract available


  4. NAKANO Y, Jones T, McLaren R, Plumb L, et al
    Nephrology review frequency, associated factors, and outcomes among people with chronic kidney disease G5: a population-based cohort study in England.
    J Nephrol. 2026 Sep 10:aajag242. doi: 10.1093.
    PubMed     Abstract available


  5. SCHRETEROVA E, Rosenberger J, Baltesova T, Dohal M, et al
    Mycobacterium fortuitum as a Cause of Refractory Culture-Negative Peritonitis in a Peritoneal Dialysis Patient.
    J Nephrol. 2026 Sep 5:aajag235. doi: 10.1093.
    PubMed    


  6. KAPPAOUGIOUMTZIDOU O, Michou V, Intzevidou E, Lamprou V, et al
    Associations between physical activity levels and self-perceived quality of life and well-being in hemodialysis patients and their informal caregivers: a multicenter cross-sectional study.
    J Nephrol. 2026 Sep 3:aajag180. doi: 10.1093.
    PubMed     Abstract available


  7. YILDIRIM S, Turgay G, Bal AZ, Tutal E, et al
    Olfactory dysfunction in hemodialysis patients: baseline differences and longitudinal changes compared with healthy controls.
    J Nephrol. 2026 Sep 3:aajag186. doi: 10.1093.
    PubMed     Abstract available


  8. PARK S, Chun P
    Chronic kidney disease progression with proton pump inhibitors versus H2 receptor antagonists in NSAID users.
    J Nephrol. 2026 Sep 3:aajag176. doi: 10.1093.
    PubMed     Abstract available


    August 2026
  9. YILDIRIM UZ B, Gunes Gencer GY, Bora F
    Effects of a telehealth-supported home-based exercise program on functional capacity, sarcopenia risk, and patient-reported outcomes in non-dialysis stage 4-5 chronic kidney disease.
    J Nephrol. 2026 Aug 31:aajag172. doi: 10.1093.
    PubMed     Abstract available


  10. GENOVESI S, Regolisti G, Ferraro PM, Bianchi S, et al
    Thromboembolic prophylaxis in kidney failure patients with atrial fibrillation undergoing hemodialysis: from risk stratification to decision making on anticoagulants or left atrial appendage closure. A position paper endorsed by the Italian Society of
    J Nephrol. 2026 Aug 26:aajag233. doi: 10.1093.
    PubMed     Abstract available


  11. RICCIO E, Gambardella J, Cuomo V, Iaccarino G, et al
    Feasibility and safety of pegunigalsidase alfa infusion during hemodialysis: first case report in a Fabry patient with kidney failure.
    J Nephrol. 2026 Aug 25:aajag159. doi: 10.1093.
    PubMed    


  12. SILVA MZC, Vogt BP, Avesani CM, Costa FL, et al
    Muscle Quality Index in Patients on Peritoneal Dialysis: Association with Clinical and Nutritional Factors.
    J Nephrol. 2026 Aug 25:aajag231. doi: 10.1093.
    PubMed     Abstract available


  13. COHEN EP, Gibson IW, Denic A, Poudel C, et al
    Stenosis of the glomerulotubular neck with chronic kidney disease.
    J Nephrol. 2026 Aug 25:aajag165. doi: 10.1093.
    PubMed     Abstract available


  14. KIM J, Kosaki K, Mori S, Matsui M, et al
    Associations of sedentary behavior and physical activity with serum uric acid in middle-aged and older adults with and without chronic kidney disease.
    J Nephrol. 2026 Aug 25:aajag232. doi: 10.1093.
    PubMed     Abstract available


  15. MULE M, Bertoni D, Tedesco M, Terlizzi V, et al
    Psychological challenges of patients starting peritoneal dialysis: a single-center qualitative pilot study.
    J Nephrol. 2026 Aug 24:aajag142. doi: 10.1093.
    PubMed     Abstract available


  16. AL WAHIDI H, Habash B, Khelfa Y, Mustafa RA, et al
    Dialysis and renal transplantation in Gaza: a crisis of access in a war zone.
    J Nephrol. 2026 Aug 24:aajag161. doi: 10.1093.
    PubMed     Abstract available


  17. ZHANG Y, Yan Y, Yang S, Wang C, et al
    Exploring the association between perceived control, psychological flexibility, and hope among hemodialysis patients: a cross-sectional observational study.
    J Nephrol. 2026 Aug 24:aajag123. doi: 10.1093.
    PubMed     Abstract available


  18. MURCUTT G, Goodlad C, Davenport A
    The impact of reducing dialysate flows during haemodiafiltration and haemodialysis sessions.
    J Nephrol. 2026;39:785-791.
    PubMed     Abstract available


  19. STRIPPOLI GFM, Pellegrino G, Hegbrant J, Fabbrini P, et al
    Online hemodiafiltration for kidney failure: guidance and best clinical practice recommendations from the Italian Society of Nephrology.
    J Nephrol. 2026 Aug 19:aajag225. doi: 10.1093.
    PubMed     Abstract available


  20. BARRACLOUGH KA
    Beyond Waste: Circular Design and the Reimagining of Sustainable Dialysis.
    J Nephrol. 2026 Aug 18:aajag162. doi: 10.1093.
    PubMed    


  21. KAMIDO H, Hasebe M, Su CY, Sawa N, et al
    Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.
    J Nephrol. 2026 Aug 18:aajag136. doi: 10.1093.
    PubMed    


  22. DABILY ME, Salem H, Moussallem M, Demirdjian MJ, et al
    Nutrition-Focused Physical Examination and Functional Phenotypes Are Associated with Fall Risk in Hemodialysis Patients: A Prospective Pilot Study.
    J Nephrol. 2026 Aug 17:aajag222. doi: 10.1093.
    PubMed     Abstract available


  23. RIBEIRO CMR, Strogoff-de-Matos JP, Barra ABL, Canziani MEF, et al
    Analysis of adjudicated causes of death in a large cohort of Brazilian patients undergoing dialysis.
    J Nephrol. 2026 Aug 14:aajag152. doi: 10.1093.
    PubMed     Abstract available


  24. YAJIMA T, Arao M
    Associations between novel myosteatosis indices measured by computed tomography and muscle strength in patients undergoing hemodialysis.
    J Nephrol. 2026 Aug 14:aajag146. doi: 10.1093.
    PubMed     Abstract available


  25. KAYA MH, Buyukturan O, Buyukturan B, Alkan H, et al
    Structured exercise improves vascular access and functional outcomes in hemodialysis patients: a randomized controlled trial.
    J Nephrol. 2026 Aug 14:aajaf070. doi: 10.1093.
    PubMed     Abstract available


  26. TENTOLOURIS A, Filippatos T, Katsikas T, Samarkos M, et al
    Prevalence of Chronic Kidney Disease in Hospitalized Patients in Internal Medicine Wards in Greece: The CKD-HOP Point Prevalence Study.
    J Nephrol. 2026 Aug 13:aajag207. doi: 10.1093.
    PubMed     Abstract available


  27. HANNANE N, Schmaderer C, Mayer CC, Matschkal J, et al
    Nocturnal Respiratory Rate Predicts 3-Year Mortality in Hemodialysis.
    J Nephrol. 2026 Aug 12:aajag206. doi: 10.1093.
    PubMed     Abstract available


  28. KHAN U, Rotenberg S, Cameron JI, Oliver MJ, et al
    Assessing Patients' ability to learn medication protocols during a hemodialysis session.
    J Nephrol. 2026 Aug 12:aajag099. doi: 10.1093.
    PubMed     Abstract available


  29. GRANATA A, Maccarrone R, Sturiale A, Dipasqua F, et al
    The therapeutic potential of peritoneal dialysis in congenital heart diseases. A lesson for the clinical nephrologist.
    J Nephrol. 2026 Aug 12:aajag110. doi: 10.1093.
    PubMed    


  30. ARIC M, Meltem E, Adiyaman Z, Alagoz S, et al
    Association between sarcopenia and inflammation in non-geriatric patients with chronic kidney disease: a comparison of hemodialysis and non-hemodialysis patients.
    J Nephrol. 2026 Aug 12:aajag120. doi: 10.1093.
    PubMed     Abstract available


  31. TOTARO M, Comparcini D, Simonetti V, Pastore F, et al
    Digital health literacy in patients with chronic kidney disease: a cross-sectional study.
    J Nephrol. 2026 Aug 12:aajag118. doi: 10.1093.
    PubMed     Abstract available


  32. YILDIRIM S, Bulut M, Gonen S, Helvaci O, et al
    Ultrasound-based peritoneal membrane thickness as a marker of inflammation and technique failure in peritoneal dialysis.
    J Nephrol. 2026 Aug 6:aajag069. doi: 10.1093.
    PubMed     Abstract available


  33. TORREGGIANI M, Abdulrub R, Rutigliano AG, Piccoli GB, et al
    Use of a sampler to collect spent dialysate in hemodialysis: a technical note.
    J Nephrol. 2026 Aug 6:aajag217. doi: 10.1093.
    PubMed     Abstract available


    July 2026
  34. MALAWEERA A, Huang LL, McMahon LP
    Dialysis adequacy assessment in peritoneal dialysis: A survey of current practice in Australia and New Zealand.
    J Nephrol. 2026 Jul 30:aajag208. doi: 10.1093.
    PubMed     Abstract available


  35. ANUDUANG N, Kanjanabuch T, Towannang P, Visedthorn S, et al
    From inference to proof: nanopore sequencing confirms zoonotic Neisseria Zoodegmatis peritonitis after cat bite-related contamination in a patient on automated peritoneal dialysis.
    J Nephrol. 2026 Jul 28:aajag089. doi: 10.1093.
    PubMed     Abstract available


  36. NASO E, Fabbrini P, Marengo M, Fiorentino M, et al
    Real-world management of dialysis-requiring acute kidney injury in Italy: a national survey of nephrology centers.
    J Nephrol. 2026 Jul 28:aajag088. doi: 10.1093.
    PubMed     Abstract available


  37. FANG Y, Shao Y, Lin X, Xu Q, et al
    Efficacy and safety of finerenone with or without combination therapy in patients with non-diabetic chronic kidney disease: a real-world observational study.
    J Nephrol. 2026 Jul 28:aajag094. doi: 10.1093.
    PubMed     Abstract available


  38. SPATOLA L, Maccarrone R, Zeiler M, Granata A, et al
    Lp(a) in chronic kidney disease: state of the art and management perspectives.
    J Nephrol. 2026 Jul 28:aajag084. doi: 10.1093.
    PubMed     Abstract available


  39. BOSSOLA M, Senatore A, Di Stasio E
    High inter-dialytic weight gain is associated with an increased risk of insomnia in patients on chronic hemodialysis.
    J Nephrol. 2026 Jul 23:aajag134. doi: 10.1093.
    PubMed    


  40. OKADA M, Inaguma D, Sato T, Himeno T, et al
    Comparison of preemptive living-donor kidney transplantation with incident hemodialysis in Japan: a region-specific analysis from a setting with limited deceased-donor kidney transplantation.
    J Nephrol. 2026 Jul 23:aajag075. doi: 10.1093.
    PubMed     Abstract available


  41. HUGHES A, Wu R, Jaure A, Coghlan D, et al
    Impacts of research that are meaningful to people with chronic kidney disease and their caregivers: a workshop report.
    J Nephrol. 2026 Jul 23:aajag205. doi: 10.1093.
    PubMed     Abstract available


  42. MONTAZER SM, Asadi A, Taghipour A, Rajabi A, et al
    Impact of HIF-prolyl hydroxylase inhibitors on VEGF expression and vascular adverse events in chronic kidney disease: a meta-analysis of 34 randomized controlled trials.
    J Nephrol. 2026 Jul 23:aajag065. doi: 10.1093.
    PubMed     Abstract available


  43. PETRAUSKIENE V, Hellberg M, Svensson P, Clyne N, et al
    Association between bone turnover markers and bone mineral density after 12 months of exercise in patients with chronic kidney disease stages 3-5: a post-hoc exploratory sub-study of the RENEXC randomized controlled trial.
    J Nephrol. 2026 Jul 21:aajag203. doi: 10.1093.
    PubMed     Abstract available


  44. DE NICOLA L, Reboldi G, Fioretto P, Pontremoli R, et al
    Healthcare cost offsets associated with empagliflozin for the treatment of chronic kidney disease in Italy: a budget impact analysis.
    J Nephrol. 2026 Jul 20:aajag019. doi: 10.1093.
    PubMed     Abstract available


  45. ARDAVANI A, Curtis F, Highton P, Khunti K, et al
    Developing a core outcome set for pharmacist interventions in chronic kidney disease: a Delphi study.
    J Nephrol. 2026 Jul 20:aajag005. doi: 10.1093.
    PubMed     Abstract available


  46. ZARE M, Abaj F, Pourghaznein T, Behnam H, et al
    Effect of virtual education and follow-up on health literacy and resilience in family caregivers of pediatric hemodialysis patients: a randomized controlled trial.
    J Nephrol. 2026 Jul 20:aajag015. doi: 10.1093.
    PubMed     Abstract available


  47. CHANG E, Anne LJ
    Compact green dialysis: circular economy approach to advancing sustainability in resource-limited health-care settings.
    J Nephrol. 2026 Jul 18:aajag050. doi: 10.1093.
    PubMed     Abstract available


  48. ADEJUMO OA, Oyedepo DS, Edeki IR, Busari KA, et al
    Prevalence of protein-energy wasting among non-dialytic and dialytic chronic kidney disease patients in Africa: a systematic review and meta-analysis.
    J Nephrol. 2026 Jul 17:aajaf084. doi: 10.1093.
    PubMed     Abstract available


  49. TARRASS F, Benjelloun M
    Designing a grid-connected solar photovoltaic system for a dialysis center based on an energy audit.
    J Nephrol. 2026 Jul 16:aajag049. doi: 10.1093.
    PubMed     Abstract available


  50. LUCIO GARCIA PIRES AC, Homem Mansur A, Dutra G, Costa GM, et al
    Effect of hemodialysis and fluid removal on lung function in patients with kidney failure-a pre-post study.
    J Nephrol. 2026 Jul 8:aajag057. doi: 10.1093.
    PubMed     Abstract available


    June 2026
  51. TRIGO F, Bessa J, Tavares J, Alves R, et al
    A sustainable future for peritoneal dialysis: a patient survey on green nephrology.
    J Nephrol. 2026 Jun 26:aajag073. doi: 10.1093.
    PubMed     Abstract available


  52. RYCEN J, Santagada S, Srivastava V
    Lessons for the clinical nephrologist: adjuvant taurolidine in selected patients with relapsing peritoneal dialysis-related peritonitis.
    J Nephrol. 2026 Jun 26:aajag045. doi: 10.1093.
    PubMed    


  53. YUEH FR, Xu D, Lee HF, Sung JM, et al
    Longitudinal trajectories in multidomain frailty among patients with chronic kidney disease.
    J Nephrol. 2026 Jun 26:aajag085. doi: 10.1093.
    PubMed    



  54. Correction to: Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.
    J Nephrol. 2026 Jun 26:aajag167. doi: 10.1093.
    PubMed    


  55. PEZOULAS VC, Tachos N, Fotiadis DI, Tripepi G, et al
    From challenge to innovation: a narrative review on innovation in nephrology and hemodialysis randomized trials.
    J Nephrol. 2026 Jun 25:aajag032. doi: 10.1093.
    PubMed     Abstract available


  56. TARRASS F, Benjelloun O, Habib Allah M, Benjelloun M, et al
    A cost-benefit and sustainability model for high-efficiency reverse osmosis implementation in Moroccan Dialysis Centers.
    J Nephrol. 2026 Jun 25:aajaf011. doi: 10.1093.
    PubMed     Abstract available


  57. ABIFARAJ F, Ghandour EC, Jaar BG
    Successful pregnancy while maintained on peritoneal dialysis: lessons for the clinical nephrologist.
    J Nephrol. 2026 Jun 22:aajag059. doi: 10.1093.
    PubMed    


  58. TAN CY, Ng SX, Ng YX, He HG, et al
    The effectiveness of educational intervention on knowledge and health outcomes among patients undergoing peritoneal dialysis: a systematic review and meta-analysis.
    J Nephrol. 2026 Jun 16:aajaf064. doi: 10.1093.
    PubMed     Abstract available


  59. TORREGGIANI M, Waugh J
    I get greener (with a little help from my patients). Patients as key drivers of greener peritoneal dialysis.
    J Nephrol. 2026 Jun 16:aajag078. doi: 10.1093.
    PubMed    


  60. DI MARIO F, Zeppilli L, Morabito S, Tozzi P, et al
    Tailoring dialysis prescription in a critically ill patient with AKI: the role of Regional Citrate Anticoagulation as a tool for acid-base optimization.
    J Nephrol. 2026 Jun 16:aajag009. doi: 10.1093.
    PubMed     Abstract available


  61. GHANEM R, Yazbek A, Idilbi A, Alhalabi A, et al
    Abdominal arterial calcification profile in kidney transplant candidates: a comparison between patients with autosomal dominant polycystic kidney disease and those with other causes of kidney failure.
    J Nephrol. 2026;39:399-407.
    PubMed     Abstract available


  62. MUSTAFA A, Agarwal A, Wei C, Amor M, et al
    Renalism: an obstacle to left heart catheterization in chronic kidney disease patients.
    J Nephrol. 2026 Jun 16:aajaf048. doi: 10.1093.
    PubMed     Abstract available


  63. CASSANI DE OLIVEIRA M, Rufino L, Mendes Lourenco AL, Correa EA, et al
    Effects of gliflozins on bone health of patients with chronic kidney disease: a systematic review.
    J Nephrol. 2026 Jun 16:aajag035. doi: 10.1093.
    PubMed     Abstract available


  64. LIU T, Dai Y, Sun Y, Zhou J, et al
    Association between famine exposure during early life and the risk of chronic kidney disease in adulthood: a systematic review and meta-analysis.
    J Nephrol. 2026 Jun 16:aajaf074. doi: 10.1093.
    PubMed     Abstract available


  65. BURTON JO, Gallieni MA, Jacobson SH, Molina P, et al
    Prevalence and burden of chronic kidney disease-associated pruritus in Europe (CENSUS-EU).
    J Nephrol. 2026 Jun 15:aajag038. doi: 10.1093.
    PubMed     Abstract available


  66. SALAMAH S, Post A, Alkaff FF, Heiner-Fokkema MR, et al
    Association of carnitine levels with muscle status, fatigue, and mortality in hemodialysis patients.
    J Nephrol. 2026 Jun 8:aajaf068. doi: 10.1093.
    PubMed     Abstract available


  67. D'ALESSANDRO C, Brambilla Pisoni M, Pagnucci S, Del Grosso A, et al
    Accuracy of SARC-F test for screening of sarcopenia in adult dialysis patients.
    J Nephrol. 2026 Jun 5:aajaf072. doi: 10.1093.
    PubMed     Abstract available


  68. WONG L, Schembri E, McMahon LP
    Frailty and sarcopenia in dialysis patients: a double burden with clinical impact.
    J Nephrol. 2026 Jun 2:aajaf073. doi: 10.1093.
    PubMed    


  69. ARAMPATZIS S, Ernandez T, Teta D, Bonani M, et al
    New insights into the management of secondary hyperparathyroidism in non-dialysis dependent chronic kidney disease: extended release calcifediol.
    J Nephrol. 2026 Jun 2:aajaf008. doi: 10.1093.
    PubMed     Abstract available


  70. VILLARROEL P, Arancibia M, Lorca E, Ardiles L, et al
    Case report: nutritional intervention supplemented with ketoanalogues in chronic kidney disease during pregnancy.
    J Nephrol. 2026 Jun 2:aajag018. doi: 10.1093.
    PubMed     Abstract available


    May 2026
  71. ALHAMMOURI H, Ibrahim R, Alasmar R, Dreher L, et al
    Z-coded social determinants of health and cardiovascular risk among patients receiving dialysis.
    J Nephrol. 2026 May 26:aajaf060. doi: 10.1093.
    PubMed     Abstract available


  72. ABDULAZIZ HMM, Mahmoud R, Attiya AMN, Sultan BO, et al
    Decoding hemodialysis patients' symptoms: navigating the complexity.
    J Nephrol. 2026 May 26:aajaf047. doi: 10.1093.
    PubMed     Abstract available


  73. KATO K, Nakashima A, Aizawa C, Hayashi A, et al
    Programmed cell death 1 pathway and cognitive function in patients undergoing hemodialysis.
    J Nephrol. 2026 May 19:aajag048. doi: 10.1093.
    PubMed     Abstract available


  74. ZHOU W, Sun C, Huang J, Cao W, et al
    Knowledge, attitude, and practice toward arteriovenous fistula self-care among maintenance hemodialysis patients with diabetic kidney disease.
    J Nephrol. 2026 May 19:aajag026. doi: 10.1093.
    PubMed     Abstract available


  75. BELLUCCI C, Mora P, Pavone L, Radice LM, et al
    Sudden bilateral ocular pain, conjunctival redness and blurred vision with halos at hemodialysis start: an eye of attention for the nephrologist! Lessons for the Clinical Nephrologist.
    J Nephrol. 2026 May 19:aajag039. doi: 10.1093.
    PubMed    


  76. FURUKAWA E, Okuhara T
    Living, traveling, and dialysis: a qualitative analysis of patient experiences shared in an online forum.
    J Nephrol. 2026 May 19:aajag017. doi: 10.1093.
    PubMed     Abstract available


  77. JAIN M, Babu R, Jain A
    Phosphate binders and the gut microbiota in chronic kidney disease: mechanisms, mixed evidence, and clinical considerations.
    J Nephrol. 2026 May 19:aajag023. doi: 10.1093.
    PubMed     Abstract available


  78. BAINHA ACC, Pinheiro BV, de Jesus LADS, Lucinda LMF, et al
    Do we really know the prevalence of frailty in patients undergoing hemodialysis?
    J Nephrol. 2026 May 18:aajag007. doi: 10.1093.
    PubMed    


  79. WONTANATAWATOT W, Kanjanabuch T, Chuengsaman P, Boonyakrai C, et al
    Dual RAAS blockade preserves peritoneal membrane function and residual kidney function in incident peritoneal dialysis patients: a randomized controlled trial.
    J Nephrol. 2026 May 18:aajaf032. doi: 10.1093.
    PubMed    


  80. LEITE AR, Vale C, Marques P, Mendonca L, et al
    Thiazide use and MRA eligibility in type 2 diabetes with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    J Nephrol. 2026 May 18:aajag001. doi: 10.1093.
    PubMed    


  81. BOISSIERE-O'NEILL T, Takashima M, Lazarus B, Vilcins D, et al
    Blood environmental chemical exposure levels among adults with chronic kidney disease: a cross-sectional NHANES study.
    J Nephrol. 2026 May 18:aajaf042. doi: 10.1093.
    PubMed     Abstract available


  82. YAU YK, Hu Z, Li M, Quan J, et al
    Indirect effect of the COVID-19 pandemic on mortality, complications, and healthcare utilization among people with Chronic Kidney Disease in Hong Kong: an interrupted time series analysis.
    J Nephrol. 2026 May 11:aajaf051. doi: 10.1093.
    PubMed     Abstract available


  83. COPUR S, Ozbek L, Basile C, Kanbay M, et al
    Peripheral artery disease in chronic kidney disease: an underestimated comorbidity.
    J Nephrol. 2026 May 7:aajaf014. doi: 10.1093.
    PubMed     Abstract available


    April 2026
  84. SANTOS AS, Dufour I, Morelle J, Goffin E, et al
    An integrated home dialysis model facilitates transition from peritoneal dialysis to self-care hemodialysis: evidence from a Belgian cohort.
    J Nephrol. 2026 Apr 17:aajag004. doi: 10.1093.
    PubMed     Abstract available


  85. NERI L, Viglino G
    Results of a new model of videotraining for patients and caregivers for peritoneal dialysis: food for (AI) thought?
    J Nephrol. 2026 Apr 7:aajaf027. doi: 10.1093.
    PubMed     Abstract available


  86. NARDELLI L, Scalamogna A, Sikharulidze A, Tripodi F, et al
    The choice of peritoneal dialysis catheter design: variants and clinical implications.
    J Nephrol. 2026 Apr 1:aajaf031. doi: 10.1093.
    PubMed     Abstract available


  87. GARY-BOBO P, Bayat S, Naveiro D, Siebert M, et al
    Chronic kidney disease stage 4 and 5: comparison of therapeutic projects before kidney replacement therapy between men and women in Brittany.
    J Nephrol. 2026 Apr 1:aajaf001. doi: 10.1093.
    PubMed     Abstract available


    March 2026
  88. KEANE DF, Trinca D, Mussnig S, Krenn S, et al
    Volume status in dialysis patients at extreme body habitus: a prospective observational study.
    J Nephrol. 2026 Mar 16:aajaf018. doi: 10.1093.
    PubMed     Abstract available


  89. NAKANO H, Yabe H, Takahashi R, Yamaguchi T, et al
    Effect of intradialytic exercise therapy on life outcomes in maintenance hemodialysis patients: a multicenter study.
    J Nephrol. 2026 Mar 10:aajaf026. doi: 10.1093.
    PubMed     Abstract available


  90. CASINO FG, Casino A, Basile C
    The European Renal Calculator (EuReCa) app: a user-friendly tool for calculating dialysis dose in incremental hemodialysis.
    J Nephrol. 2026 Mar 10:aajaf028. doi: 10.1093.
    PubMed     Abstract available


  91. MERMET C, Desmarquets A, Bertocchio JP, Florens N, et al
    Impact of chronic kidney disease on sexual health: a survey of dialysis and transplant patients at Strasbourg University Hospital.
    J Nephrol. 2026 Mar 3:aajaf005. doi: 10.1093.
    PubMed    


  92. LENTINI P, Bianchi S, Viglino G, Pieruzzi F, et al
    Transforming chronic kidney disease care with telemedicine: expert consensus recommendations from the Italian Society of Nephrology.
    J Nephrol. 2026 Mar 3:aajaf007. doi: 10.1093.
    PubMed     Abstract available


    February 2026
  93. OBEN AI
    The dialysis cycle.
    J Nephrol. 2026 Feb 23:aajaf029. doi: 10.1093.
    PubMed    


  94. FLAHAULT A, Keck M, Kersraoui D, Beaudreuil S, et al
    Copeptin is a reliable biomarker of vasopressin and is associated with urine osmolality in patients on peritoneal dialysis.
    J Nephrol. 2026 Feb 4:aajaf021. doi: 10.1093.
    PubMed     Abstract available


  95. MEZZATESTA S, Fiumara G, D'Antoni F, Provenzano PF, et al
    Symptom burden in dialysis patients: determinants and impact on mortality.
    J Nephrol. 2026 Feb 3:aajaf013. doi: 10.1093.
    PubMed     Abstract available


  96. HAROON SWP, Lau T, Lee BW, Leung MKN, et al
    Carbon footprint of a Singapore satellite hemodialysis center.
    J Nephrol. 2026 Feb 3:aajaf009. doi: 10.1093.
    PubMed     Abstract available


  97. LOBO AS, Vaughan L, Ainsworth AJ, Felt M, et al
    Sex hormones and sexual health in chronic kidney disease before and after kidney transplantation.
    J Nephrol. 2026 Feb 3:aajaf022. doi: 10.1093.
    PubMed     Abstract available


    December 2025
  98. HULL KL, Bugeja A, Graham-Brown MPM, Reid L, et al
    Exploring vascular access survival in prevalent thrice-weekly in-centre nocturnal haemodialysis patients.
    J Nephrol. 2025;38:2651-2661.
    PubMed     Abstract available


    November 2025
  99. PETERSEN NA, Schultz ANO, Falster C, Kampmann JD, et al
    Lung ultrasound for fluid assessment in patients receiving dialysis-a systematic review.
    J Nephrol. 2025 Nov 3. doi: 10.1007/s40620-025-02435.
    PubMed     Abstract available


  100. LARKIN J, Alfano G, Ligabue G, Cadenas RM, et al
    Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy.
    J Nephrol. 2025 Nov 1. doi: 10.1007/s40620-025-02416.
    PubMed     Abstract available


  101. WONG ETY, Liew IT, Than H, Ho AYL, et al
    Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore.
    J Nephrol. 2025;38:2041-2052.
    PubMed     Abstract available


    October 2025
  102. KANAKUBO Y, Inanaga R, Toida T, Aita T, et al
    Correction: Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: a cross-sectional study.
    J Nephrol. 2025 Oct 29. doi: 10.1007/s40620-025-02457.
    PubMed    


  103. ITO S, Matsumoto M, Shimono A, Teranishi H, et al
    Characteristics and clinical courses of patients with atypical haemolytic uraemic syndrome on dialysis withdrawal after eculizumab treatment: sub-analysis of post-marketing surveillance in Japan.
    J Nephrol. 2025 Oct 28. doi: 10.1007/s40620-025-02433.
    PubMed     Abstract available


  104. PAGES H, Kosmadakis G, Kanouni FE, Necoara A, et al
    Evaluation of multidisciplinary care pathways on kidney function in patients with advanced chronic kidney disease: multicenter study.
    J Nephrol. 2025 Oct 27. doi: 10.1007/s40620-025-02365.
    PubMed     Abstract available


  105. QIAO Y, Gao S, Li S, Pei H, et al
    The association between empirical antibiotic regimens and the outcome of peritoneal dialysis-related peritonitis: a multi-center, large-scale cohort study.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02437.
    PubMed     Abstract available


  106. CHOQUET Q, Novel-Catin E, Laubacher M, Massat M, et al
    Contrast-induced encephalopathy after cerebral aneurysm embolization in a chronic hemodialysis patient: a case-report.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02374.
    PubMed    


  107. ELKERAIE A, Elraggal M, AbouKhatwa M, Omar ME, et al
    Safety of SGLT2 inhibitors in chronic kidney disease patients during Ramadan fasting: a prospective cohort study.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02438.
    PubMed     Abstract available


  108. CHUANG GT, Hsiung CN, Che TP, Oh KH, et al
    Correction: Genome-wide polygenic risk score for estimated glomerular filtration slope predicts chronic kidney disease in a Taiwanese population.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02456.
    PubMed    


  109. YAJIMA T, Arao M
    Unilateral psoas muscle sarcopenic indices, all-cause mortality, and novel cardiovascular events in patients undergoing hemodialysis.
    J Nephrol. 2025 Oct 19. doi: 10.1007/s40620-025-02450.
    PubMed    


  110. PARIBELLO G, Papa F, Ganzerli MC, Pisani A, et al
    Semaglutide in overweight non-diabetic peritoneal dialysis patients: a real-world single-center experience.
    J Nephrol. 2025 Oct 8. doi: 10.1007/s40620-025-02453.
    PubMed    


  111. MUSTAFA A, Yermekbay A, Zhankorazova A, Toktarbay B, et al
    Hemodynamic effects of hemodialysis: the interaction between the heart and the arteries.
    J Nephrol. 2025 Oct 7. doi: 10.1007/s40620-025-02434.
    PubMed     Abstract available


  112. MAHIC O, van Lieshout TS, Abrahams AC, Driehuis E, et al
    Longitudinal associations between iron status and patient-reported outcomes in incident dialysis patients: a DOMESTICO substudy.
    J Nephrol. 2025 Oct 2. doi: 10.1007/s40620-025-02363.
    PubMed     Abstract available


    September 2025
  113. OLSZEWSKI M, Bjurstrom K, Lingman M, Henrohn D, et al
    Differences in chronic kidney disease management based on identification and diagnosis in a population-based observational study.
    J Nephrol. 2025 Sep 26. doi: 10.1007/s40620-025-02414.
    PubMed     Abstract available


  114. DIXON A, You Z, Richey R, Furgeson S, et al
    Effects of sodium bicarbonate therapy on cognitive function in chronic kidney disease (ancillary study): a randomized controlled trial.
    J Nephrol. 2025 Sep 25. doi: 10.1007/s40620-025-02429.
    PubMed    


  115. KAMPMANN JD, Stel VS, Christensen LS, Kramer A, et al
    Socioeconomic factors and access to home dialysis and early kidney transplantation across Europe.
    J Nephrol. 2025 Sep 19. doi: 10.1007/s40620-025-02424.
    PubMed    


  116. JAYOUSI S, Cinelli M, Bigazzi R, Bianchi S, et al
    Functionality and sustainability of telemedicine for home-based management of patients with chronic kidney disease: the telemechron study.
    J Nephrol. 2025 Sep 18. doi: 10.1007/s40620-025-02348.
    PubMed     Abstract available


  117. RODRIGUES HCN, de Oliveira Sousa AG, Preto VRM, de Paula Cunha LN, et al
    Low physical function is a risk factor for mortality in non-dialysis-dependent chronic kidney disease patients.
    J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02420.
    PubMed    


  118. LARKIN J, Ligabue G, Alfano G, Cadenas RM, et al
    A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement.
    J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02409.
    PubMed     Abstract available


  119. LOUTATI R, Copeland V, Klempfner R, Ben-Zekry S, et al
    The effect of chronic kidney disease on the association of tricuspid regurgitation with overall survival : Insights from SHEBAHEART big data.
    J Nephrol. 2025 Sep 15. doi: 10.1007/s40620-025-02377.
    PubMed     Abstract available


  120. ZEILER M, Mancini A, Federico A, Ramazzotti V, et al
    Dynamic functional examination of the peritoneal dialysis catheter using color Doppler ultrasound. In vitro technical evaluation and in vivo application.
    J Nephrol. 2025 Sep 13. doi: 10.1007/s40620-025-02421.
    PubMed     Abstract available


  121. SCHMILL P, Seaton N, Greenwood S, Hudson JL, et al
    Do psycho-behavioural interventions improve mental and physical health in chronic kidney disease? A systematic review of randomised controlled trials.
    J Nephrol. 2025 Sep 10. doi: 10.1007/s40620-025-02372.
    PubMed     Abstract available


  122. MARCH DS, Bernhardt L, Barber K, Curtis F, et al
    Prevalence and characteristics of treatments for sleep disordered breathing in people receiving dialysis: a scoping review.
    J Nephrol. 2025 Sep 9. doi: 10.1007/s40620-025-02370.
    PubMed     Abstract available


  123. FERIOZZI S, Battaglia Y, Cirami CL, Gangemi C, et al
    The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology.
    J Nephrol. 2025 Sep 8. doi: 10.1007/s40620-025-02406.
    PubMed     Abstract available


  124. CHUANG GT, Hsiung CN, Che TP, Oh KH, et al
    Genome-wide polygenic risk score for estimated glomerular filtration slope predicts chronic kidney disease in a Taiwanese population.
    J Nephrol. 2025 Sep 4. doi: 10.1007/s40620-025-02380.
    PubMed     Abstract available


  125. SUZUKI Y, Kamiya K, Hoshi K, Tanaka S, et al
    Effects of electrical muscle stimulation during hemodialysis in older patients with frailty: a crossover randomized controlled trial.
    J Nephrol. 2025 Sep 3. doi: 10.1007/s40620-025-02383.
    PubMed     Abstract available


  126. SAWIRES H, Abdallah S, Ramadan M, Abdel-Halim R, et al
    Osteocalcin as a predictor of bone fracture in children with chronic kidney diseases.
    J Nephrol. 2025 Sep 3. doi: 10.1007/s40620-025-02385.
    PubMed     Abstract available


  127. WANG X, He J, Wang Y
    Long-term outcomes following acute kidney injury in individuals with pre-existing chronic kidney disease: a systematic review and meta-analysis.
    J Nephrol. 2025 Sep 1. doi: 10.1007/s40620-025-02373.
    PubMed     Abstract available


    August 2025
  128. VAN HOVE P, Vleut R, Ligthart S
    Hypertonic continuous venovenous hemodialysis managing nontraumatic subdural hematoma in a hemodialysis patient. A lesson for the clinical nephrologist.
    J Nephrol. 2025 Aug 28. doi: 10.1007/s40620-025-02344.
    PubMed    


  129. JAQUES DA, Dufey A, Alves C, De Seigneux S, et al
    Importance of age and timing of referral when initiating dialysis.
    J Nephrol. 2025 Aug 26. doi: 10.1007/s40620-025-02390.
    PubMed     Abstract available


  130. FERRARA P, Rozza D, Antonazzo IC, Zamparini M, et al
    Awareness and management of stage 3 chronic kidney disease among primary care practitioners in Italy: a nation-wide observational study.
    J Nephrol. 2025 Aug 24. doi: 10.1007/s40620-025-02384.
    PubMed     Abstract available


  131. GHONEIM M, Davenport A
    Frailty compared to sarcopenia as the predictor of mortality for elderly hemodialysis patients.
    J Nephrol. 2025 Aug 21. doi: 10.1007/s40620-025-02368.
    PubMed     Abstract available


  132. CAPELLI I, De Benedictis M, Di Lenarda A, Di Maso V, et al
    Optimizing urine albumin-to-creatinine ratio testing and referral pathways for chronic kidney disease: a nominal group technique consensus study among Italian experts.
    J Nephrol. 2025 Aug 20. doi: 10.1007/s40620-025-02371.
    PubMed     Abstract available


  133. KANAKUBO Y, Inanaga R, Toida T, Aita T, et al
    Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: a cross-sectional study.
    J Nephrol. 2025 Aug 19. doi: 10.1007/s40620-025-02387.
    PubMed     Abstract available


  134. GROBMAN B, Mansur A, Lu CY
    Social vulnerability and chronic kidney disease-associated mortality in the United States: 1999-2020.
    J Nephrol. 2025 Aug 4. doi: 10.1007/s40620-025-02369.
    PubMed     Abstract available


    July 2025
  135. PARK SJ, Kim YN, Oh BK, Yu H, et al
    Efficacy and safety of antithrombotics in patients with atrial fibrillation undergoing hemodialysis: a nationwide cohort study in Korea.
    J Nephrol. 2025 Jul 31. doi: 10.1007/s40620-025-02340.
    PubMed     Abstract available


  136. ZHAO L, Shang J, Shi Y, Yan Y, et al
    Quantifying ultrasound echogenicity difference for accurate chronic kidney disease diagnosis.
    J Nephrol. 2025 Jul 30. doi: 10.1007/s40620-025-02352.
    PubMed     Abstract available


  137. YUN HR, Joo YS, Kim HW, Park JT, et al
    Type 2 diabetes mellitus modifies the relationship between coronary artery calcification and adverse kidney outcome in patients with chronic kidney disease: the findings from KNOW-CKD.
    J Nephrol. 2025 Jul 30. doi: 10.1007/s40620-025-02364.
    PubMed     Abstract available


  138. KO B, Ko YE, Jung CY, Kang DH, et al
    Association of accelerometer-measured physical activity with adverse cardiovascular outcomes in individuals with or without chronic kidney diseases: the UK biobank study.
    J Nephrol. 2025 Jul 28. doi: 10.1007/s40620-025-02345.
    PubMed     Abstract available


  139. PIVETEAU J, Bayat S, Vigneau C, Couchoud C, et al
    The evolution of consultation practices with general practitioners and nephrologists for patients with chronic kidney disease before and after the COVID-19 pandemic in France.
    J Nephrol. 2025 Jul 27. doi: 10.1007/s40620-025-02376.
    PubMed     Abstract available


  140. HANNANE N, Mayer CC, Matschkal J, Bormann F, et al
    Long-term prediction of mortality by heart rate turbulence in hemodialysis patients and the impact of diabetes mellitus-a longitudinal observational study.
    J Nephrol. 2025 Jul 15. doi: 10.1007/s40620-025-02357.
    PubMed     Abstract available


  141. LIGHTFOOT CJ, Wilkinson TJ, Graham-Brown MPM, Smith AC, et al
    Supporting people with chronic kidney disease to self-manage their condition: understanding the lived experiences, needs and requirements, and barriers and facilitators.
    J Nephrol. 2025 Jul 12. doi: 10.1007/s40620-025-02349.
    PubMed     Abstract available


  142. KASRADZE T, Didbaridze T, Tchokhonelidze I
    Impact of sodium bicarbonate locking solution on catheter-related blood stream infection in hemodialysis patients: comparative effectiveness of three locks.
    J Nephrol. 2025 Jul 1. doi: 10.1007/s40620-025-02315.
    PubMed     Abstract available


    June 2025
  143. PROUVOT J, Reboul P, Ahmadpoor P, Clemmer E, et al
    Performance of the Kidney Failure Risk Equation according to diabetic status in the CKD-CAREMEAU cohort of patients with chronic kidney disease.
    J Nephrol. 2025 Jun 19. doi: 10.1007/s40620-025-02286.
    PubMed     Abstract available


  144. BEZERRA R, Feitosa ADM, Barbosa R, Aguiar FC, et al
    Assessing the reliability of self-reported home blood pressure measurements in dialysis patients.
    J Nephrol. 2025 Jun 10. doi: 10.1007/s40620-025-02324.
    PubMed    


  145. MURASHIMA M, Fujii N, Goto S, Hasegawa T, et al
    Correction: Residual kidney function modifies the effect of cinacalcet on serum phosphorus levels among peritoneal dialysis patients.
    J Nephrol. 2025 Jun 10. doi: 10.1007/s40620-025-02333.
    PubMed    


  146. CHA'ON U, Aranyapal A, Lertsinudom S, Japrung D, et al
    Prevalence and risk factors of chronic kidney disease of unknown etiology in Northeast Thailand.
    J Nephrol. 2025 Jun 10. doi: 10.1007/s40620-025-02302.
    PubMed     Abstract available


  147. FERRARO PM, Arbustini E, Bellino D, Caletti C, et al
    Primary hyperoxaluria type 1 diagnosis in adult dialysis patients: prediction model assessment in a group of Italian patients.
    J Nephrol. 2025 Jun 4. doi: 10.1007/s40620-025-02243.
    PubMed     Abstract available


  148. CALISKAN Y, Yildiz A, Aypek H, Oto OA, et al
    Comparative validation of the Mayo Clinic imaging classification and PROPKD score for predicting ADPKD progression across diverse ethnic cohorts.
    J Nephrol. 2025;38:1469-1477.
    PubMed     Abstract available


    May 2025
  149. DONDJIO JEMELE LJ, Buzzi M, Petipa Nga O, Couchoud C, et al
    Oral health care among dialysis patients in France and impact on survival.
    J Nephrol. 2025 May 30. doi: 10.1007/s40620-025-02307.
    PubMed     Abstract available


  150. TARRASS F, Benjelloun M, Razkaoui A, Benjelloun O, et al
    Sustainable reuse of hemodialysis reject water for potato farming: a large-scale feasibility study in Morocco.
    J Nephrol. 2025 May 23. doi: 10.1007/s40620-025-02295.
    PubMed     Abstract available


  151. ALDER H, Gaspert A, Fuster DG
    Adenine phosphoribosyltransferase deficiency as a rare cause of rapidly progressive chronic kidney disease.
    J Nephrol. 2025 May 14. doi: 10.1007/s40620-025-02304.
    PubMed    


  152. RAJAN AK, Khader NA, Poojari PG, Attur RP, et al
    Development, validation, and reliability of a questionnaire to assess risk-factors of chronic kidney disease of unknown etiology.
    J Nephrol. 2025 May 12. doi: 10.1007/s40620-025-02297.
    PubMed     Abstract available


  153. BERTAZZA PARTIGIANI N, D'Uva A, Vigezzi S, Brazzale AR, et al
    Comparative efficacy of epoetin alfa vs. darbepoetin in children with chronic kidney disease: a systematic review, meta-analysis and cost-effectiveness analysis.
    J Nephrol. 2025 May 11. doi: 10.1007/s40620-025-02303.
    PubMed     Abstract available


  154. MURAKAMI M, Aoki T, Sugiyama Y, Sasaki S, et al
    Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.
    J Nephrol. 2025 May 8. doi: 10.1007/s40620-025-02299.
    PubMed     Abstract available


  155. ALFANO G, Albinelli A, Ferri C, Romaniello R, et al
    Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life.
    J Nephrol. 2025 May 6. doi: 10.1007/s40620-025-02281.
    PubMed     Abstract available


    April 2025
  156. D'ALESSANDRO C, Giannese D, Piccoli GB, Panichi V, et al
    Ketogenic diets in chronic kidney disease patients: a review for skeptics by skeptics.
    J Nephrol. 2025 Apr 30. doi: 10.1007/s40620-025-02285.
    PubMed     Abstract available


  157. PERROTTA AM, Piccoli GB, Di Giandomenico M, Rotondi S, et al
    Preliminary results of a questionnaire aimed at evaluating the carbon footprint of hemodialysis facilities.
    J Nephrol. 2025 Apr 29. doi: 10.1007/s40620-025-02301.
    PubMed    


  158. CAMPO A, Goia F, Cottino R, Gandolfo C, et al
    Reduced intensity incremental hemodialysis start does not decrease life expectancy and saves money: results of the RIDDLE study.
    J Nephrol. 2025 Apr 23. doi: 10.1007/s40620-025-02271.
    PubMed     Abstract available


  159. RAFFRAY M, Campeon A, Bricard D, Auge E, et al
    Learning from the implementation phase of the new French capitation payment model for chronic kidney disease care: a qualitative study.
    J Nephrol. 2025 Apr 22. doi: 10.1007/s40620-025-02284.
    PubMed     Abstract available


  160. INNECCHI MLR, Avesani CM, Coelho VA, Lauar JC, et al
    Outpatient clinic for older patients with chronic kidney disease: a model of a multidisciplinary care model.
    J Nephrol. 2025 Apr 20. doi: 10.1007/s40620-025-02293.
    PubMed     Abstract available


  161. MORI D, Hayashi M, Honda R, Tanoue H, et al
    Short-term prognostic score for very elderly patients, aged 85 or older, initiating hemodialysis.
    J Nephrol. 2025 Apr 15. doi: 10.1007/s40620-025-02292.
    PubMed     Abstract available


  162. GRYCUK W, Jakubowska Z, Malyszko J
    Proenkephalin (PENK): a functional biomarker in chronic kidney diseases - hope or just a new bystander?
    J Nephrol. 2025 Apr 15. doi: 10.1007/s40620-025-02268.
    PubMed     Abstract available


  163. CLAUSE AL, Dethier P, Piccoli GB, Gambino G, et al
    Pregnancy on short daily home hemodialysis using low flow dialysate. A narrative review of the literature and a new case report.
    J Nephrol. 2025 Apr 11. doi: 10.1007/s40620-025-02265.
    PubMed     Abstract available


  164. HUH H, Han K, Kim M, Shin YS, et al
    Early-stage chronic kidney disease as a risk factor for suicide: a nationwide observational cohort study.
    J Nephrol. 2025 Apr 9. doi: 10.1007/s40620-025-02219.
    PubMed     Abstract available


  165. RAJA N, Radhakrishnan H, Masilamani S, Jothy AA, et al
    Family Income and Employment Status Play an Important Role in The Quality of Life of Hemodialysis Patients in a Resource-Limited Setting.
    J Nephrol. 2025 Apr 5. doi: 10.1007/s40620-025-02254.
    PubMed     Abstract available


  166. DAVY A, Oberg CM, Boyer A, Lanot A, et al
    Bimodal solutions in peritoneal dialysis: what can we expect from different glucose volumes added to the icodextrin bag? Data from a simulation procedure.
    J Nephrol. 2025 Apr 1. doi: 10.1007/s40620-025-02206.
    PubMed     Abstract available


    March 2025
  167. SAKA Y, Naruse T, Katsurayama Y, Sato Y, et al
    Serum zinc level is associated with aortic arch calcification in incident dialysis patients.
    J Nephrol. 2025 Mar 29. doi: 10.1007/s40620-025-02283.
    PubMed     Abstract available


  168. PONCE D, Bannwart J, Silva MZC, Zamoner W, et al
    Peritoneal dialysis in acute kidney injury: twenty years of experience at a single center in a developing country.
    J Nephrol. 2025 Mar 29. doi: 10.1007/s40620-024-02189.
    PubMed     Abstract available


  169. TRAISE A, Dieberg G, Degotardi E, Hart B, et al
    The effect of exercise training on quality of life in people with chronic kidney disease requiring dialysis. A systematic review with meta-analysis.
    J Nephrol. 2025 Mar 28. doi: 10.1007/s40620-025-02245.
    PubMed     Abstract available


  170. KAMEL NA, Stokes MA, Wright DFB, Sud K, et al
    Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review.
    J Nephrol. 2025 Mar 25. doi: 10.1007/s40620-025-02269.
    PubMed     Abstract available


  171. HUYNH DQ, Huynh HTT, Trieu NHK, Tran AH, et al
    Regional citrate anticoagulation for continuous renal replacement therapy: a prospective study in a resource-limited intensive care unit from Vietnam.
    J Nephrol. 2025 Mar 16. doi: 10.1007/s40620-025-02255.
    PubMed     Abstract available


  172. YAVORSKIY P, Borrelli S, Esposito K, Maiorino MI, et al
    Lesson for the clinical nephrologist: glucagon-like peptide-1 receptor agonists (GLP-1 RA) in a patient with obesity and diabetic kidney disease on peritoneal dialysis.
    J Nephrol. 2025 Mar 14. doi: 10.1007/s40620-025-02247.
    PubMed    


  173. MORISI N, Alfano G, Ferrarini M, Ferri C, et al
    Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification.
    J Nephrol. 2025 Mar 12. doi: 10.1007/s40620-025-02257.
    PubMed     Abstract available


  174. ZADEK F, Brunoni B, Mulazzani F, Sironi I, et al
    Acid-base implications of the Gibbs-Donnan effect during continuous veno-venous hemofiltration.
    J Nephrol. 2025 Mar 10. doi: 10.1007/s40620-025-02238.
    PubMed     Abstract available


  175. GOK E, Sahin MK
    Chronic kidney disease awareness: a cross-sectional study in primary care settings in Turkiye.
    J Nephrol. 2025 Mar 8. doi: 10.1007/s40620-025-02210.
    PubMed     Abstract available


  176. SHAILLY S, Hawkins J, Kirschner R, Naranjo FS, et al
    Lead intoxication in end-stage kidney disease: a lesson for the clinical nephrologist.
    J Nephrol. 2025 Mar 8. doi: 10.1007/s40620-025-02215.
    PubMed    


  177. OKUBO A, Doi T, Morii K, Nishizawa Y, et al
    Predicting 3-year all-cause mortality in patients undergoing hemodialysis using machine learning.
    J Nephrol. 2025 Mar 6. doi: 10.1007/s40620-025-02236.
    PubMed     Abstract available


  178. MALBERTI F, Possenti S, Pecchini P, Lucca B, et al
    Treatment of secondary hyperparathyroidism in hemodialysis patients: a comparison between two Italian centers to evaluate real-world guideline implementation.
    J Nephrol. 2025 Mar 5. doi: 10.1007/s40620-025-02227.
    PubMed     Abstract available


  179. SCHMIDT R, Parravani A, Poling M, Diab A, et al
    Home dialysis as the incident modality in patients starting dialysis in West Virginia: role of the rural outreach kidney care clinic.
    J Nephrol. 2025 Mar 1. doi: 10.1007/s40620-025-02223.
    PubMed     Abstract available


  180. MORI D, Tamai S, Nomi H, Nagatoya K, et al
    Effect of finerenone in patients with diabetes and advanced chronic kidney disease.
    J Nephrol. 2025 Mar 1. doi: 10.1007/s40620-025-02244.
    PubMed    


  181. MANNAN F, Chinnadurai R, Wiltshire R, Hansel J, et al
    Epidemiology and early predictors of Fabry nephropathy: evaluation of long-term outcomes from a national Fabry centre.
    J Nephrol. 2025;38:579-587.
    PubMed     Abstract available


    February 2025
  182. FABBRINI P, Pieruzzi F, Bellocchio F, Casana Eslava R, et al
    The prognostic reasoning system for chronic kidney disease progression (PROGRES-CKD) may help improve waiting list management for outpatient nephrology services in a second-level public hospital in Italy.
    J Nephrol. 2025 Feb 27. doi: 10.1007/s40620-025-02222.
    PubMed     Abstract available


  183. UTHAYARAJAN N, Jayawardene KLTD, Weerasekara I
    Quality and sources of food and water consumed by people with chronic kidney disease of unknown etiology in Sri Lanka: a systematic review.
    J Nephrol. 2025 Feb 26. doi: 10.1007/s40620-024-02174.
    PubMed     Abstract available


  184. MARXER CA, Paik JM, Zhuo M, Desai RJ, et al
    Changes in serum creatinine during and after pregnancy in female patients with or without chronic kidney disease: an observational study in UK primary care data.
    J Nephrol. 2025 Feb 26. doi: 10.1007/s40620-025-02208.
    PubMed    


  185. WANG T, Goh JX, Seth S, Do LL, et al
    Chronic kidney disease-associated pruritus and patient-centred outcomes: a systematic review.
    J Nephrol. 2025 Feb 25. doi: 10.1007/s40620-025-02221.
    PubMed     Abstract available


  186. KOBAYASHI D, Ganse M, Shinoda T, Hamada C, et al
    A survey on the association between patient activation and quality of life among patients with chronic kidney disease in Japan.
    J Nephrol. 2025 Feb 24. doi: 10.1007/s40620-025-02235.
    PubMed     Abstract available


  187. CAROLLO C, Mancia E, Sorce A, Altieri C, et al
    Prognostic impact of neutrophil-to-lymphocyte ratio and vascular access in patients on chronic hemodialysis.
    J Nephrol. 2025 Feb 17. doi: 10.1007/s40620-024-02203.
    PubMed     Abstract available


  188. HAN J, Zhang H, Li X, Tang Y, et al
    Relationship between dietary consumption of live microbes with mortality in adults with chronic kidney disease.
    J Nephrol. 2025 Feb 12. doi: 10.1007/s40620-025-02212.
    PubMed     Abstract available


  189. CHU G, Matricciani L, Russo S, Viecelli AK, et al
    Sleep disturbances in adults with chronic kidney disease: an umbrella review.
    J Nephrol. 2025 Feb 8. doi: 10.1007/s40620-025-02214.
    PubMed     Abstract available


  190. KOSMADAKIS G, Necoara A, Baudenon J, Deville C, et al
    Sleep disorders in hemodialysis patients.
    J Nephrol. 2025 Feb 7. doi: 10.1007/s40620-025-02229.
    PubMed    


  191. HUSEYNLI B, Akkuzu E, Buyukkaragoz B, Bakkaloglu SA, et al
    Hyperammonemic encephalopathy requiring hemodialysis in a child with distal renal tubular acidosis.
    J Nephrol. 2025 Feb 7. doi: 10.1007/s40620-025-02218.
    PubMed     Abstract available


  192. ANKAWI G
    Nurses' knowledge and perspectives on pregnancy among dialysis patients.
    J Nephrol. 2025 Feb 5. doi: 10.1007/s40620-025-02232.
    PubMed     Abstract available


  193. KARUR AK, Kumar P, Nayak-Rao S
    Lessons for the clinical nephrologist: a rare presentation of extrapulmonary tuberculosis in a hemodialysis patient.
    J Nephrol. 2025 Feb 4. doi: 10.1007/s40620-024-02183.
    PubMed    


  194. DI MARIO F, Regolisti G, Fani F, Menegazzo B, et al
    Sustained Low-Efficiency Dialysis (SLED) with Regional Citrate Anticoagulation (RCA) and new dialysis equipment: a prospective study with serum citrate measurements and electrolyte monitoring.
    J Nephrol. 2025 Feb 1. doi: 10.1007/s40620-024-02201.
    PubMed     Abstract available


    January 2025
  195. MISHRA SR, Mehata S, Khanal V, Shrestha N, et al
    Tackling chronic kidney disease in Nepal: from evidence to action.
    J Nephrol. 2025 Jan 29. doi: 10.1007/s40620-024-02200.
    PubMed     Abstract available


  196. YAJIMA T, Arao M
    Psoas muscle gauge and adverse clinical outcomes in patients on hemodialysis.
    J Nephrol. 2025 Jan 28. doi: 10.1007/s40620-024-02191.
    PubMed     Abstract available


  197. COOPER AL, Panizza N, Bartlett R, Martin-Robins D, et al
    A period prevalence study of palliative care need and provision in adult patients attending hospital-based dialysis units.
    J Nephrol. 2025 Jan 27. doi: 10.1007/s40620-024-02193.
    PubMed     Abstract available


  198. CHOI C, Kim MG, Kim JH
    Reno-protective effects of xanthine oxidase inhibitors in patients with type 2 diabetes and chronic kidney disease: a systematic review and meta-analysis.
    J Nephrol. 2025 Jan 27. doi: 10.1007/s40620-024-02199.
    PubMed     Abstract available


  199. TAKAHASHI R, Yabe H, Ishikawa H, Hibino T, et al
    Effectiveness of rehabilitation in hospitalized hemodialysis patients as compared with rehabilitation in hospitalized patients not on hemodialysis: a retrospective cohort study.
    J Nephrol. 2025 Jan 23. doi: 10.1007/s40620-024-02192.
    PubMed     Abstract available


  200. LACAVE F, Dufour I, Jamar F, Goffin E, et al
    An unexpected cause of dyspnea in a peritoneal dialysis patient: the hidden connection.
    J Nephrol. 2025 Jan 14. doi: 10.1007/s40620-024-02132.
    PubMed    


  201. BISWAS P, Sahu AK, Sahoo SK, Ahmed SN, et al
    Prevalence of chronic kidney disease and anemia in Hirakud Command Area, Odisha, India: unveiling the role of environmental toxicants.
    J Nephrol. 2025 Jan 12. doi: 10.1007/s40620-024-02169.
    PubMed     Abstract available


  202. STEVEN M, Reboul P, Gerbal M, Moranne O, et al
    Early diagnosis of tuberculous peritonitis after starting peritoneal dialysis.
    J Nephrol. 2025 Jan 9. doi: 10.1007/s40620-024-02190.
    PubMed    


  203. MOUHEB A, Lambert O, Alencar de Pinho N, Jacquelinet C, et al
    Association between urate-lowering therapy and kidney failure in patients with chronic kidney disease.
    J Nephrol. 2025 Jan 8. doi: 10.1007/s40620-024-02179.
    PubMed     Abstract available


  204. GU JH, Chonchol M, Hoffman C, Miyazaki M, et al
    Deoxycholic acid and the risk of death and cardiovascular events among patients with advanced chronic kidney disease.
    J Nephrol. 2025 Jan 3. doi: 10.1007/s40620-024-02185.
    PubMed    


    December 2024
  205. ROSTOKER G, Rouanet S, Merzoug M, Chakaroun H, et al
    mRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infection.
    J Nephrol. 2024 Dec 20. doi: 10.1007/s40620-024-02161.
    PubMed    


  206. MACIAS-CERVANTES HE, Ocampo-Apolonio MA, Guardado-Mendoza R, Baron-Manzo M, et al
    Effect of vitamin K1 supplementation on coronary calcifications in hemodialysis patients: a randomized controlled trial.
    J Nephrol. 2024 Dec 16. doi: 10.1007/s40620-024-02154.
    PubMed     Abstract available


  207. MICHON-COLIN A, Lombardi Y, Seret G, Lavainne F, et al
    Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer.
    J Nephrol. 2024 Dec 15. doi: 10.1007/s40620-024-02162.
    PubMed    


  208. ZAIDAN N, Jalloul Y, Goldfarb DS, Azar H, et al
    Opioid use and poisoning in hospitalized patients with chronic kidney disease.
    J Nephrol. 2024 Dec 1. doi: 10.1007/s40620-024-02159.
    PubMed     Abstract available


    November 2024
  209. CALDERON MARTINEZ E, Sanchez Cruz C, Diarte Acosta EY, Aguirre Cano DA, et al
    Efficacy and safety of novel anticoagulant therapies in patients with chronic kidney disease-a systematic review and meta-analysis.
    J Nephrol. 2024 Nov 29. doi: 10.1007/s40620-024-02130.
    PubMed     Abstract available


  210. NAKANO Y, Mandai S, Mori Y, Ando F, et al
    Nationwide mortality following acute type B aortic dissection and the survival advantage of obesity among dialysis patients in Japan.
    J Nephrol. 2024 Nov 27. doi: 10.1007/s40620-024-02147.
    PubMed     Abstract available


  211. BARBIERI G, Cazzoletti L, Melotti R, Hantikainen E, et al
    Development and evaluation of a kidney health questionnaire and estimates of chronic kidney disease prevalence in the Cooperative Health Research in South Tyrol (CHRIS) study.
    J Nephrol. 2024 Nov 27. doi: 10.1007/s40620-024-02157.
    PubMed     Abstract available


  212. WALLEZ T, Fernandes G, Dragean CA, Moryoussef M, et al
    Computed tomography peritoneography to explore peritoneal dialysis dysfunction: a Nephrology picture.
    J Nephrol. 2024 Nov 25. doi: 10.1007/s40620-024-02155.
    PubMed    


  213. PORTA DJ, Carrillo MN, Perez HA, Rivoira MA, et al
    Assessment of total carotid plaque area progression in patients with chronic kidney disease. Good practices for decision-making.
    J Nephrol. 2024 Nov 23. doi: 10.1007/s40620-024-02146.
    PubMed     Abstract available


  214. YANG M, Liu X, Chen Y, Chen X, et al
    Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis.
    J Nephrol. 2024 Nov 22. doi: 10.1007/s40620-024-02134.
    PubMed     Abstract available


  215. RICCI L, Couchoud C, Carvalho A, Buzzi M, et al
    A feasibility study for understanding the demand and acceptability of a systematic symptom monitoring process in end-stage kidney disease.
    J Nephrol. 2024 Nov 21. doi: 10.1007/s40620-024-02153.
    PubMed    


  216. BOLD E, Richardson KL, Al-Uzri A, Craven SF, et al
    Internet use and health literacy among pediatric chronic kidney disease patients and their caregivers.
    J Nephrol. 2024 Nov 18. doi: 10.1007/s40620-024-02136.
    PubMed     Abstract available


  217. MANENTI L, Marcellusi A, Di Brino E, Aiello A, et al
    Cost effectiveness of difelikefalin for the treatment of patients with chronic kidney disease-associated pruritus undergoing hemodialysis in Italy.
    J Nephrol. 2024 Nov 8. doi: 10.1007/s40620-024-02144.
    PubMed     Abstract available


  218. DOGAN O, Acar AGT, Gul M, Safak O, et al
    Predictors of acute kidney injury in chronic kidney disease patients treated for cardiovascular disease in the cardiac intensive care unit (MORCOR-TURK subgroup analysis).
    J Nephrol. 2024 Nov 8. doi: 10.1007/s40620-024-02127.
    PubMed     Abstract available


  219. CATON E, Aird R, Da Silva-Gane M, Sridharan S, et al
    Communicating health risk in chronic kidney disease: a scoping review.
    J Nephrol. 2024 Nov 8. doi: 10.1007/s40620-024-02098.
    PubMed     Abstract available


  220. DE NICOLA L, Cupisti A, D'Alessandro C, Gesualdo L, et al
    Integrating the new pharmacological standard of care with traditional nutritional interventions in non-dialysis CKD.
    J Nephrol. 2024 Nov 7. doi: 10.1007/s40620-024-02135.
    PubMed     Abstract available


  221. COGLEY C, Smith-Jones M, Ralston ER, Bramham J, et al
    Premature mortality and disparities in kidney healthcare for people with chronic kidney disease and severe mental health difficulties.
    J Nephrol. 2024 Nov 2. doi: 10.1007/s40620-024-02103.
    PubMed     Abstract available


  222. LI M, Chang D, Zhao Y, Wu L, et al
    Urinary renal tubular epithelial cells and casts as predictors of renal outcomes in patients with biopsy-proven diabetic nephropathy.
    J Nephrol. 2024;37:2233-2242.
    PubMed     Abstract available


    October 2024
  223. KIM SE, Jung SH, Yang J, Kim H, et al
    Association between urine creatinine excretion and bone mineral density in chronic kidney disease: Results from the KNOW-CKD study.
    J Nephrol. 2024 Oct 29. doi: 10.1007/s40620-024-02123.
    PubMed     Abstract available


  224. SANTOS GPA, Sesso R, Lugon JR, de Menezes Neves PDM, et al
    Geographic inequities in hemodialysis access: a call to reassess dialysis facility locations in Brazil.
    J Nephrol. 2024 Oct 25. doi: 10.1007/s40620-024-02120.
    PubMed     Abstract available


  225. KANBAY M, Copur S, Yilmaz ZY, Mallamaci F, et al
    Ziltivekimab for anemia and atherosclerosis in chronic kidney disease: a new hope?
    J Nephrol. 2024 Oct 25. doi: 10.1007/s40620-024-02117.
    PubMed     Abstract available


  226. TRAISE A, Dieberg G, Pearson MJ, Smart NA, et al
    The effect of exercise training in people with pre-dialysis chronic kidney disease: a systematic review with meta-analysis.
    J Nephrol. 2024 Oct 17. doi: 10.1007/s40620-024-02081.
    PubMed     Abstract available


  227. CHO S, Kim M, Jung S, Cho JM, et al
    Potential benefits of hormone replacement therapy on cardiovascular and kidney outcomes in postmenopausal women with chronic kidney disease.
    J Nephrol. 2024 Oct 16. doi: 10.1007/s40620-024-02099.
    PubMed     Abstract available


  228. PIROVANO M, Ganini C, Gallieni M, Porta C, et al
    Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology.
    J Nephrol. 2024 Oct 15. doi: 10.1007/s40620-024-02102.
    PubMed     Abstract available


  229. BOONSTRA MD, do Amaral MSG, Navis G, Stegmann ME, et al
    Effectiveness of a health literacy intervention targeting both chronic kidney disease patients and health care professionals in primary and secondary care: a quasi-experimental study.
    J Nephrol. 2024 Oct 4. doi: 10.1007/s40620-024-02058.
    PubMed     Abstract available


  230. AVESANI CM, Garcia-Testal A, Mesa-Gresa P, Marin AE, et al
    Peer-to-peer training among health care professionals working in dialysis clinics: an education approach from the GoodRENal project.
    J Nephrol. 2024 Oct 1. doi: 10.1007/s40620-024-02074.
    PubMed     Abstract available


    September 2024
  231. CHEN CH, Tsai PH, Tsai WC, Ko MJ, et al
    Efficacy and safety of ketoanalogue supplementation combined with protein-restricted diets in advanced chronic kidney disease: a systematic review and meta-analysis.
    J Nephrol. 2024 Sep 28. doi: 10.1007/s40620-024-02065.
    PubMed     Abstract available


  232. KANBAY M, Mizrak B, Copur S, Basile C, et al
    Cognitive impairment in patients on dialysis: can we prevent it?
    J Nephrol. 2024 Sep 21. doi: 10.1007/s40620-024-02093.
    PubMed     Abstract available


  233. LEUNG KC, Mahony S, Brown EA, Corbett RW, et al
    Factors affecting intraperitoneal pressure (IPP) and its prognostic value in predicting leak risk and gastrointestinal symptoms in adult peritoneal dialysis patients: a systematic review and meta-analysis.
    J Nephrol. 2024 Sep 16. doi: 10.1007/s40620-024-02091.
    PubMed     Abstract available


  234. WANG Z, Ma X, Li S, Pei H, et al
    Association between serum potassium, risk and prognosis of peritonitis in peritoneal dialysis patients - results from the Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study.
    J Nephrol. 2024 Sep 15. doi: 10.1007/s40620-024-02056.
    PubMed     Abstract available


  235. WU Y, Xu X, Wenxiang Q, Dong J, et al
    Coping model, personality traits, social support and clinical outcomes in patients undergoing continuous ambulatory peritoneal dialysis: a post-hoc analysis of a randomized trial.
    J Nephrol. 2024 Sep 14. doi: 10.1007/s40620-024-02090.
    PubMed     Abstract available


  236. VRDOLJAK I, Pozaic A, Bituh M, Leko N, et al
    Education and cooking methods in the management of calcium and PTH serum levels in patients on hemodialysis: a randomized controlled study.
    J Nephrol. 2024 Sep 13. doi: 10.1007/s40620-024-02024.
    PubMed     Abstract available


  237. CHIMENTI G, Magli A, Spanu G, Santagati G, et al
    Visual supports and informative material not to forget counselling on reproductive health in dialysis: a point of view.
    J Nephrol. 2024 Sep 13. doi: 10.1007/s40620-024-02059.
    PubMed     Abstract available


  238. BATTAGLIA Y, Baciga F, Bulighin F, Amicone M, et al
    Physical activity and exercise in chronic kidney disease: consensus statements from the Physical Exercise Working Group of the Italian Society of Nephrology.
    J Nephrol. 2024 Sep 13. doi: 10.1007/s40620-024-02049.
    PubMed     Abstract available


  239. MILOVANOVA LY, Nezhdanov KS, Milovanova SY, Lebedeva MV, et al
    alpha-Klotho is associated with cardiovascular and all-cause mortality in patients with stage 3b and 4 chronic kidney disease (CKD): a long-term prospective cohort study.
    J Nephrol. 2024 Sep 2. doi: 10.1007/s40620-024-02069.
    PubMed     Abstract available


  240. ALFIERI C, Molinari P, Vettoretti S, Fusaro M, et al
    Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation.
    J Nephrol. 2024 Sep 2. doi: 10.1007/s40620-024-02055.
    PubMed     Abstract available


  241. LOMBARDI G, Votrico V, Ferraro PM, Tassi S, et al
    Intradialytic serum phosphate variations are associated with low PTH levels.
    J Nephrol. 2024;37:1911-1919.
    PubMed     Abstract available


  242. PANICHI V, Rosati A, Mangione EA, Incognito F, et al
    Serum alkaline phosphatase is a strong predictor of mortality in ESKD patients: analysis of the RISCAVID cohort.
    J Nephrol. 2024;37:1843-1851.
    PubMed     Abstract available


  243. BUTT U, Davenport A, Sridharan S, Farrington K, et al
    A practical approach to implementing incremental haemodialysis.
    J Nephrol. 2024;37:1791-1799.
    PubMed     Abstract available


    August 2024
  244. KINPAYOM P, Banjongjit A, Towannang P, Rerknimitr R, et al
    Salvaging intraluminal peritoneal dialysis catheter obstruction from blood clot with a targeted thrombolytic agent: an innovation.
    J Nephrol. 2024 Aug 30. doi: 10.1007/s40620-024-02075.
    PubMed     Abstract available


  245. DONATO B, Almeida R, Raimundo M, Velho S, et al
    Myosteatosis: an underrecognized risk factor for mortality in non-dialysis chronic kidney disease patients.
    J Nephrol. 2024 Aug 12. doi: 10.1007/s40620-024-02042.
    PubMed     Abstract available


  246. PANUCCIO VA, Tripepi R, Versace MC, Russo D, et al
    Dialysis after contrast agent administration in patients on chronic hemodialysis: do all Italian nephrologists think the same way?
    J Nephrol. 2024 Aug 9. doi: 10.1007/s40620-024-01999.
    PubMed    


  247. BOLIGNANO D, Greco M, Presta P, Duni A, et al
    Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study.
    J Nephrol. 2024 Aug 5. doi: 10.1007/s40620-024-02032.
    PubMed     Abstract available


    July 2024
  248. FUJIIKE DT, Santos LL, Silveira de Andrade L, Meneses GC, et al
    Endothelium-related biomarkers, hyperphosphatemia and mortality in hemodialysis patients: a moderation analysis.
    J Nephrol. 2024 Jul 31. doi: 10.1007/s40620-024-02033.
    PubMed    


  249. MANSUR A, Grobman B, Lu CY
    Suicide among patients with chronic kidney disease in the United States: 1999-2020.
    J Nephrol. 2024 Jul 31. doi: 10.1007/s40620-024-02016.
    PubMed    


  250. LI J, Liu J, Chen P, Ma H, et al
    Cluster analysis-based classification of fatigue in stable maintenance hemodialysis patients: a prospective cohort study.
    J Nephrol. 2024 Jul 30. doi: 10.1007/s40620-024-02037.
    PubMed     Abstract available


  251. TORREGGIANI M, Esposito C
    Vascular access in incremental hemodialysis: is less always more?
    J Nephrol. 2024 Jul 29. doi: 10.1007/s40620-024-02021.
    PubMed    


  252. PAOLA N
    Ethical and legal aspects of end of life in dialysis patients: an Italian point of view.
    J Nephrol. 2024 Jul 29. doi: 10.1007/s40620-024-01996.
    PubMed     Abstract available


  253. KHALIL MA, Kasem MF, El-Hakim IZ, Abd Elhafez AM, et al
    Key performance indicators for monitoring of anemia management and iron status in children attending a pediatric dialysis unit: the experience of Ain Shams University.
    J Nephrol. 2024 Jul 18. doi: 10.1007/s40620-024-02017.
    PubMed     Abstract available


  254. MAMVEN M, Adejumo OA, Edeki IR, Oyedepo DS, et al
    Perspectives of relatives of patients with end-stage kidney disease on kidney sources, commercial kidney donation, and barriers to living kidney donation in Nigeria: a qualitative study.
    J Nephrol. 2024 Jul 16. doi: 10.1007/s40620-024-02019.
    PubMed     Abstract available


  255. JAYOUSI S, Cinelli M, Bigazzi R, Bianchi S, et al
    Telemedicine for home-based management of patients with chronic kidney diseases and comorbidities in Tuscany North-west region: a pilot study protocol (telemechron study).
    J Nephrol. 2024 Jul 15. doi: 10.1007/s40620-024-02023.
    PubMed    


  256. SANTORO A, Gibertoni D, Ambrosini A, De Ferrari ME, et al
    Correction to: Impact of pruritus in patients undergoing hemodialysis in Italy: a patient?based survey.
    J Nephrol. 2024 Jul 13. doi: 10.1007/s40620-024-02028.
    PubMed    


  257. CHEN Y, Zhang M, Li Y, Xie Q, et al
    Retroperitoneal leakage as an important cause of acquired ultrafiltration decline in peritoneal dialysis: clinical characteristics and related risk factors.
    J Nephrol. 2024 Jul 13. doi: 10.1007/s40620-024-02009.
    PubMed     Abstract available


  258. FEDELI U, Pierobon S, Grande E, Nordio M, et al
    Trends in chronic kidney disease-related mortality before and during the pandemic in Northeastern Italy.
    J Nephrol. 2024 Jul 13. doi: 10.1007/s40620-024-02020.
    PubMed    


  259. DE MASI S, Da Cas R, Ippolito FM, Baglio G, et al
    Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study.
    J Nephrol. 2024 Jul 12. doi: 10.1007/s40620-024-02007.
    PubMed     Abstract available


  260. PIROVANO M, Luciani A, Re Sarto GV, Bramati A, et al
    Osimertinib in a patient with end-stage kidney disease not on hemodialysis.
    J Nephrol. 2024 Jul 7. doi: 10.1007/s40620-024-02014.
    PubMed     Abstract available


  261. TRAN DNT, Ducher M, Fouque D, Fauvel JP, et al
    External validation of a 2-year all-cause mortality prediction tool developed using machine learning in patients with stage 4-5 chronic kidney disease.
    J Nephrol. 2024 Jul 4. doi: 10.1007/s40620-024-02011.
    PubMed     Abstract available


  262. ADEJUMO OA, Edeki IR, Sunday Oyedepo D, Falade J, et al
    Global prevalence of depression in chronic kidney disease: a systematic review and meta-analysis.
    J Nephrol. 2024 Jul 2. doi: 10.1007/s40620-024-01998.
    PubMed     Abstract available


  263. LUKOMSKI L, Pisula J, Wagner T, Sabov A, et al
    First experiences with machine learning predictions of accelerated declining eGFR slope of living kidney donors 3 years after donation.
    J Nephrol. 2024;37:1631-1642.
    PubMed     Abstract available


  264. MELLA A, Calvetti R, Barreca A, Congiu G, et al
    Kidney transplants from elderly donors: what we have learned 20 years after the Crystal City consensus criteria meeting.
    J Nephrol. 2024;37:1449-1461.
    PubMed     Abstract available


    June 2024
  265. TSALOUCHOS A, Simone G, Dattolo PC, Toccafondi A, et al
    Multidisciplinary approach to advance care planning and directives in patients with end-stage renal disease: a point of view on patient-centered decision-making.
    J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-02002.
    PubMed     Abstract available


  266. NAKAI K, Nishino T, Kagimura T, Narita I, et al
    Impact of transferrin saturation on cardiovascular events in non-dialysis-dependent chronic kidney disease patients treated with darbepoetin alfa.
    J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-02000.
    PubMed     Abstract available


  267. CHITTINANDANA P, Gojaseni P, Chuasuwan A, Singprasert R, et al
    Major adverse kidney events in multidisciplinary chronic kidney disease care compared with usual outpatient care: a propensity score matched analysis.
    J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-01994.
    PubMed     Abstract available


  268. SANTORO A, Gibertoni D, Ambrosini A, De Ferrari ME, et al
    Impact of pruritus in patients undergoing hemodialysis in Italy: a patient-based survey.
    J Nephrol. 2024 Jun 24. doi: 10.1007/s40620-024-01983.
    PubMed     Abstract available


  269. SIERRA A, Etcheverry B, Alvarez-Maestro M, Lopez JM, et al
    Management of deceased and living kidney donor with lithiasis: a multicenter retrospective study on behalf of the renal transplant group of the Spanish urological association.
    J Nephrol. 2024 Jun 22. doi: 10.1007/s40620-024-01960.
    PubMed     Abstract available


  270. MACHADO FP, Vicari AR, Bauer AC
    Assessing the impact of positive cultures in preservation fluid on renal transplant outcomes: a scoping review.
    J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01972.
    PubMed     Abstract available


  271. ERMAN HELPER O, Qasim H, Tiosano S, Abu-Amar N, et al
    Physical fitness is an independent predictor of chronic kidney disease development in apparently healthy individuals.
    J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01966.
    PubMed     Abstract available


  272. FERNANDEZ LUCAS M, Piris Gonzalez M, Diaz Dominguez ME, Collado Alsina A, et al
    Incremental hemodialysis and vascular access complications: a 12-year experience in a hospital hemodialysis unit.
    J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01932.
    PubMed     Abstract available


  273. PRZYGOCKA A, Magnoni G, Picotti M, Rapana R, et al
    Rare case of postherpetic abdominal pseudohernia in a patient on peritoneal dialysis.
    J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01954.
    PubMed     Abstract available


  274. TSENG CH, Hu YA, Chen YT, Yu WC, et al
    Beyond prevalence: significance and differential impact of echocardiographic abnormalities in dialysis patients.
    J Nephrol. 2024 Jun 4. doi: 10.1007/s40620-024-01963.
    PubMed     Abstract available


  275. TARRASS F, Benjelloun M, Piccoli GB
    Hemodialysis water reuse within a circular economy approach. What can we add to current knowledge? A point of view.
    J Nephrol. 2024 Jun 3. doi: 10.1007/s40620-024-01989.
    PubMed     Abstract available


  276. BEAL F, Forrester N, Watson E, Williams M, et al
    A targeted gene panel illuminates pathogenesis in young people with unexplained kidney failure.
    J Nephrol. 2024;37:1273-1284.
    PubMed     Abstract available


  277. MIAO J, Thongprayoon C, Craici IM, Cheungpasitporn W, et al
    How to improve ChatGPT performance for nephrologists: a technique guide.
    J Nephrol. 2024;37:1397-1403.
    PubMed     Abstract available


    May 2024
  278. MORGANTI C, Di Motta T, Andreone A, Bedogni S, et al
    Use of drug-coated balloons in the percutaneous treatment of arteriovenous fistula stenosis has a time-dependent effect: a retrospective analysis from one dialysis center.
    J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01975.
    PubMed    


  279. BEROS A, Sluyter J, Hughes A, Hametner B, et al
    Arterial stiffness and incident chronic kidney disease: a large population-based cohort study.
    J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01968.
    PubMed     Abstract available


  280. MICHOU V, Nikodimopoulou M, Liakopoulos V, Anifanti M, et al
    Home-based tele-exercise training and physical activity during the COVID-19 pandemic in chronic kidney disease patients.
    J Nephrol. 2024 May 29. doi: 10.1007/s40620-024-01976.
    PubMed     Abstract available


  281. CAUCHY L, Mousty E, Pageaux GP, Moranne O, et al
    Successful pregnancy after 10 consecutive failures in a liver transplant patient with advanced kidney failure.
    J Nephrol. 2024 May 15. doi: 10.1007/s40620-024-01936.
    PubMed     Abstract available


  282. ATTINI R, Cabiddu G, Ciabatti F, Montersino B, et al
    Correction to: Chronic kidney disease, female infertility, and medically assisted reproduction: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.
    J Nephrol. 2024 May 9. doi: 10.1007/s40620-024-01980.
    PubMed    


  283. LOCATELLI F, Del Vecchio L, Esposito C, Gesualdo L, et al
    Consensus commentary and position of the Italian Society of Nephrology on KDIGO controversies conference on novel anemia therapies in chronic kidney disease.
    J Nephrol. 2024 May 6. doi: 10.1007/s40620-024-01937.
    PubMed     Abstract available


  284. ZAPPULO F, Di Nunzio M, Donati G, Scrivo A, et al
    Vitamin E-coated membrane reversed itchy rash during hemodialysis.
    J Nephrol. 2024 May 2. doi: 10.1007/s40620-024-01941.
    PubMed    


  285. ARDISSINO G, Cresseri D, Mancuso MC, Capone V, et al
    Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition.
    J Nephrol. 2024;37:1017-1026.
    PubMed     Abstract available


  286. CETINKAYA H, Gursu M, Yazici H, Cebeci E, et al
    Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
    J Nephrol. 2024;37:923-932.
    PubMed     Abstract available


    April 2024
  287. HU H, Chau PH, Choi EPH
    Physical activity, exercise habits and health-related quality of life in maintenance hemodialysis patients: a multicenter cross-sectional study.
    J Nephrol. 2024 Apr 24. doi: 10.1007/s40620-024-01935.
    PubMed     Abstract available


  288. GENOVESI S, Bianchi S, Basile C
    Role of the left atrial appendage closure in preventing thromboembolism in atrial fibrillation: what is the importance for chronic kidney disease patients?
    J Nephrol. 2024 Apr 24. doi: 10.1007/s40620-024-01944.
    PubMed    


  289. BOSSOLA M, Picconi B
    Uremic toxins and the brain in chronic kidney disease.
    J Nephrol. 2024 Apr 16. doi: 10.1007/s40620-024-01929.
    PubMed     Abstract available


  290. NWANOSIKE EM, Merchant HA, Sunter W, Ansari MA, et al
    A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study.
    J Nephrol. 2024 Apr 2. doi: 10.1007/s40620-024-01930.
    PubMed     Abstract available


  291. YU B, Atta MG, Brennan DC, Kant S, et al
    Outcomes and management of kidney transplant recipients with Fabry disease: a review.
    J Nephrol. 2024;37:561-571.
    PubMed     Abstract available


    March 2024
  292. MAMBELLI E, Grandi F, Santoro A
    Comparison of blood volume biofeedback hemodialysis and conventional hemodialysis on cardiovascular stability and blood pressure control in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials.
    J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-023-01844.
    PubMed     Abstract available


  293. RODRIGUES HCN, Sousa AGO, Preto VRM, Ferro CMB, et al
    FRAIL scale as a screening tool and a predictor of mortality in non-dialysis dependent patients.
    J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01900.
    PubMed     Abstract available


  294. MATSUNAMI M, Suzuki T, Suzuki K, Kuji H, et al
    Resuming automated peritoneal dialysis after laparoscopic peritoneal wall anchoring for peritoneal dialysis catheter fixation.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01917.
    PubMed    


  295. MA T, Li X, Hao J, Song D, et al
    The prognostic values of estimating intraperitoneal pressure in the occurrence of abdominal wall complications in peritoneal dialysis patients.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01913.
    PubMed     Abstract available


  296. SOEDA K, Komaba H, Nakagawa Y, Kawabata C, et al
    Association of serum sodium levels with fractures and mortality in patients undergoing maintenance hemodialysis.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01904.
    PubMed     Abstract available


  297. BAYKARA ULUSAN M, Meltem E, Mutlu IN, Ulusan K, et al
    The predictive value of systemic inflammatory markers in 902 patients with tunneled hemodialysis catheter.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-023-01880.
    PubMed     Abstract available


  298. CORTVRINDT C, Van Biesen W, Gambino G, Clause AL, et al
    Factors influencing renal replacement therapy modality choice from the nephrologist's perspective.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01915.
    PubMed     Abstract available


  299. QING X, Jiang J, Yuan C, Xie K, et al
    Temporal trends in prevalence and disability of chronic kidney disease caused by specific etiologies: an analysis of the Global Burden of Disease Study 2019.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01914.
    PubMed     Abstract available


  300. SIMHADRI PK, Vaitla PK, Marathi R, Khan A, et al
    Donor-transmitted cystinuria in a renal transplant recipient.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-023-01877.
    PubMed     Abstract available


  301. REN W, Sun J, Zhang L, He W, et al
    Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
    PubMed     Abstract available


  302. RECCHIA A, Casazza R, Cozzolino M, Rizzi B, et al
    Kidney supportive care for advanced chronic and end-stage kidney disease: a retrospective cohort study.
    J Nephrol. 2024 Mar 6. doi: 10.1007/s40620-023-01879.
    PubMed     Abstract available


  303. ALFANO G, Bergesio F, Lombardi M, Piccoli GB, et al
    Eco-dialysis in Italy: where are we? National survey on the eco-sustainability of dialysis across Italian dialysis centers.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01882.
    PubMed    


  304. ROTHEM Y, Askenasy E, Siman-Tov M, Davidov Y, et al
    Elevated hemoglobin levels in renal transplant recipients with polycystic kidney disease versus other etiologies: exploring mechanisms and implications for outcomes.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01868.
    PubMed     Abstract available


  305. CHLOROGIANNIS DD, Bousi SE, Zachiotis M, Chlorogiannis A, et al
    Pre-operative ultrasound mapping before arteriovenous fistula formation: an updated systematic review and meta-analysis.
    J Nephrol. 2024;37:281-292.
    PubMed     Abstract available


    January 2024
  306. FANELLI F, Falcone G, Gabbani G, Annese AL, et al
    Multidisciplinary working group: key role for percutaneous endovascular AV fistula program. Point of view.
    J Nephrol. 2024;37:215-219.
    PubMed     Abstract available


  307. SAFDAR A, Akram W, Khan MA, Alvi MN, et al
    Comparison of Pakistani CKD-EPI, new Asian-modified CKD-EPI and revised Lund-Malmo study equations in a South Asian CKD population: a study from a Pakistani CKD cohort.
    J Nephrol. 2024;37:119-129.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum